Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines

Oral Oncology

Volumn 49, Issue 1, 2013, Pages 20-26

  Ohta, Mitsuhiko ^a,c   Abe, Atsushi ^a   Ohno, Fumi ^a   Hasegawa, Yasuhisa ^b   Tanaka, Harunari ^b   Maseki, Shinichiro ^d   Kondo, Eisaku ^b   Kurita, Kenichi ^a   Nakanishi, Hayao ^b  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c Daiyukai General Hospital   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Histone deacetylase; Oral and pharyngeal squamous cell carcinomas; Podoplanin; Squamous differentiation; TGF

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; BUTYRIC ACID; CYTOKERATIN 10; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; PODOPLANIN; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRICHOSTATIN A;

ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BENZAMIDES; BUTYRATES; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; DIOXOLES; FEMALE; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; IMMUNOHISTOCHEMISTRY; KERATIN-10; LYMPHATIC METASTASIS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PHARYNGEAL NEOPLASMS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TONGUE NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

EID: 84871433034     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.06.017     Document Type: Article

References (29)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics CA Cancer J Clin 59 2009 225 249
2. L. Vormittag, D. Thurnher, and S. Geleff Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio (chemo) therapy Int J Radiat Oncol Biol Phys 73 3 2009 913 918
3. J.P. Shah, and Z. Gil Current concepts in management of oral cancer-surgery Oral Oncol 45 4-5 2009 394 401
4. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 1 2010 21 28
5. M. Kreppel, U. Drebber, and I. Wedemeyer Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy Oral Oncol 47 9 2011 873 878
6. J.K. Nagpal, and B.R. Das Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management Oral Oncol 39 3 2003 213 221 (Pubitemid 36255687)
7. S. Breitender-Geleff, K. Matsui, and A. Soleiman Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis Am J Pathol 151 1997 1141 1152 (Pubitemid 27424324)
8. H.J. Kohn, D. Bailey, and A. Marks Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas Mod Pathol 15 4 2002 434 440 (Pubitemid 34326952)
9. K.L. Dumoff, C.S. Chu, and E.E. Harris Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation Mod Pathol 19 5 2006 708 716
10. Y. Kato, I. Sasagawa, and M. Kaneko Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors Oncogene 23 2004 8552 8556 (Pubitemid 39540806)
11. K. Mishima, Y. Kato, and M.K. Kaneko Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression Acta Neuropathol 111 5 2006 483 488
12. Y. Kato, M. Kaneko, and M. Sata Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma Tumor Biol 26 2005 195 200 (Pubitemid 41379745)
13. M. Kreppel, M. Scheer, and U. Drebber Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations Virchows Arch 456 6 2010 473 482
14. P. Yuan, S. Temam, and A. El-Naggar Overexpression of podoplanin in oral cancer and its association with poor clinical outcome Cancer 107 3 2006 563 569 (Pubitemid 44107217)
15. A. Wicki, and G. Christofori The potential role of podoplanin in tumour invasion Br J Cancer 96 1 2007 1 5 (Pubitemid 46094630)
16. G.F. Huber, F.R. Fritzsche, and L. Züllig Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx Int J Cancer 129 6 2011 1404 1409
17. M. Toyoshima, M. Nakajima, and T. Yamori Purification of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26 Cancer Res 55 1995 767 773
18. Y. Kato, N. Fujita, and A. Kunita Molecular identification of aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors J Biol Chem 278 2003 51599 51605 (Pubitemid 38020404)
19. N. Atsumi, G. Ishii, and M. Kojima Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431 Biochem Biophys Res Commun 373 2008 36 41
20. H. Suzuki, Y. Kato, and M.K. Kaneko Induction of podoplanin by transforming growth factor-β in human fibrosarcoma FEBS Lett 582 2008 341 345
21. M. Honma, M. Minami-Hori, and H. Takahashi Podoplanin expression in wound and hyperproliferative psoriatic epidermis: Regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6 and IL-22 J Dermatol Sci 65 2 2012 134 140
22. S. Ito, H. Nakanishi, and Y. Kodera Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients Br J Cancer 93 2005 986 992 (Pubitemid 41548391)
23. F. Ohno, H. Nakanishi, and A. Abe Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis J Oral Pathol Med 36 5 2007 281 289 (Pubitemid 46632611)
24. Y. Shimada, G. Ishii, and K. Nagai Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung Cancer Sci 100 11 2009 2054 2059
25. B. Hantusch, R. Kalt, and S. Krieger Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells BMC Mol Biol 8 2007 20
26. C.H. Heldin, K. Miyazono, and P. Dijke TGF-beta signaling from cell membrane to nucleus through SMAD proteins Nature 390 1997 465 471 (Pubitemid 28013118)
27. Y. Fuyuhiro, M. Yashiro, and S. Noda Cancer-associated orthotopic myofibroblasts stimulate the motility of gastric carcinoma cells Cancer Sci 103 4 2012 797 805
28. S.L. Lu, H. Herrington, and D. Reh Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma Genes Dev 20 2006 1331 1342 (Pubitemid 43727593)
29. M.A. Cortez, M.S. Nicoloso, and M. Shimizu MiR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma Genes Chromosomes Cancer 49 11 2010 981 990